DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.65 Cr | ₹1.95 Cr | ₹1.61 Cr | - | - |
What is the latest Long Term Provisions ratio of DR LAL PATHLABS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹2.65 Cr |
| Mar2025 | ₹1.95 Cr |
| Mar2024 | ₹1.61 Cr |
| Mar2023 | - |
| Mar2022 | - |
How is Long Term Provisions of DR LAL PATHLABS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.65 Cr | 36.00 | |
| Mar2025 | ₹1.95 Cr | 21.23 | |
| Mar2024 | ₹1.61 Cr | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Long Term Provisions of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹31,761.9 Cr | 4.5% | 15.5% | 21.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹126,818.0 Cr | 1.3% | 3% | 22% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹106,087.0 Cr | -1.4% | -2.6% | -11.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹71,245.4 Cr | 0.3% | -3.1% | 12% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹70,945.4 Cr | 2.3% | 4% | 36.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹39,224.0 Cr | -1.3% | 2.1% | 4.9% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 4.5% |
15.5% |
21.5% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses